Tumor size, but not consolidation‐to‐tumor ratio, is an independent prognostic factor for part‐solid clinical T1 non‐small cell lung cancer

BACKGROUND: Tumor size and consolidation‐to‐tumor ratio (CTR) are crucial for non–small cell lung cancer (NSCLC) prognosis. However, the optimal CTR cutoff remains unclear. Whether tumor size and CTR are independent prognostic factors for part‐solid NSCLC is under debate. Here, we aimed to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhihua, Xu, Wenzheng, Gu, Tianhao, Cao, Xincen, Wu, Weibing, Chen, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968594/
https://www.ncbi.nlm.nih.gov/pubmed/36578128
http://dx.doi.org/10.1111/1759-7714.14788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968594/
https://www.ncbi.nlm.nih.gov/pubmed/36578128
http://dx.doi.org/10.1111/1759-7714.14788

Ejemplares similares